The present disclosure relates generally to developing the design for a dental prosthesis to be used with a dental implant.
The dental restoration of a partially or wholly edentulous patient with artificial dentition can be accomplished through several methods involving a dental implant. One common method has two stages. In the first stage, an incision is made through the gingiva to expose the underlying bone. An artificial tooth root, in the form of a dental implant, is placed in the jawbone for osseointegration. The dental implant generally includes a threaded bore to receive a retaining screw for holding mating components thereon. During the first stage, the gum tissue overlying the implant is sutured and heals as the osseointegration process continues.
Once the osseointegration process has sufficiently advanced, the second stage is initiated. Here, the gingival tissue is re-opened to expose an end of the dental implant. A healing component or healing abutment is fastened to the exposed end of the dental implant to allow the gingival tissue to heal therearound. The healing abutment is then removed and a prosthesis, which involves an abutment and artificial crown fitting over the abutment, is secured to the dental implant through the gingival aperture created by the healing abutment.
In an alternative method, the healing abutment can be placed on the dental implant immediately after the implant has been installed and before osseointegration. In this method, the osseointegration phase and gingival-healing step into a one-step process.
In a further alternative, the dental implant can be immediately loaded by use of a temporary prosthesis placed on the dental implant after it has been installed. In that situation, the gingival tissue heals around the temporary abutment.
Regardless of the method that is used, a primary goal is to have the soft tissue heal around the prosthesis in a predictable manner (i.e., similar to the patient's adjacent teeth) so that the prosthesis and soft tissue contours appear more natural. There are, however, many clinical factors that may impact the ability of the soft tissue to grow around and be preserved against the prosthesis, including at least the following (i) the patient's age, (ii) the patient's sex, (iii) the patient's race, (iv) the location of the implant-abutment interface relative to the bone, (v) the material of the abutment, (vi) the surface treatment on the abutment, (vii) the amount of surface area of the abutment exposed to the soft tissue, (viii) the soft-tissue displacement required when placing the prosthesis at the site after the second-phase soft-tissue healing process is complete, (ix) the type of bone at the implant installation, and (x) the patient's health conditions (e.g., smoker, diabetic, etc.).
Implant dentistry restorative methods have advanced to the digital world such that the scanning of the patient's mouth, of the impression of the patient's mouth, or the model of a patient's mouth provides the information needed for restoring the case. That information can be used to develop a patient-specific (i.e., custom) prosthesis for the patient. Some examples of the technology are discussed in U.S. Pat. Nos. 8,353,703, 8,257,083, 8,185,224, which are commonly owned and hereby incorporated by reference in their entireties. In these more modern digital dentistry systems, the creation of the design (the abutment and the crown to fit on the abutment) and the finalization of the design are generally accomplished by design technicians and dental laboratory personnel using CAD-CAM software. However, in the current systems, the designs are typically based on what the current patient requires based on his or her conditions. While the design technicians and dental laboratory personnel may rely on their experiences in designing other prostheses, the success of the soft-tissue outcome on the previously designed prostheses does not play a part in the current design.
A need exists for a patient-specific restorative system that leverages the knowledge of the soft-tissue outcomes of previous patients to develop a design for a prosthesis for a current patient. In doing so, the system provides a greater certainty that the predicted soft-tissue outcome for the current patient will become a reality for the current patient.
The present invention relates to a method of designing a patient-specific prosthesis for a current patient. The method comprises receiving scan data of a mouth of the current patient to identify conditions at a location at which the patient-specific prosthesis is to be placed on a dental implant, and determining at least two clinical factors for the current patient. The method further includes identifying a desired outcome for soft tissue for the current patient at the location, and accessing a database having soft-tissue-outcome information for each of a plurality of previous patients. The database further includes clinical-factor information for each of the plurality of previous patients. Based on the soft-tissue-outcome information and the clinical-factor information for at least a first previous patient of the plurality of previous patients being related to the current patient's desired outcome and the current patient's at least two clinical factors, the method includes developing a design for the patient-specific prosthesis for the current patient that includes design features used by an actual previous prosthesis for the first previous patient.
In an alternative embodiment, a method of designing a patient-specific prosthesis for a current patient comprises accessing a database that stores information for each of a plurality of previous patients. The information for each previous patient includes (i) clinical-factor information, (ii) prosthetic information relating to the prosthesis used on the previous patient and (iii) soft-tissue-outcome information. Based on a relationship between (i) clinical factors and desired soft-tissue outcome for the current patient and (ii) the clinical-factor information and the soft-tissue-outcome information for a first previous patient from the plurality of previous patients, the method includes selecting the prosthetic information for the first previous patient as part of a baseline design for the patient-specific prosthesis, and modifying the baseline design to develop a final design for the patient-specific prosthesis.
In a further embodiment, a method of designing a dental prosthesis for a current patient comprises identifying, within a database, a previous patient from a plurality of patients that has an actual prosthesis and an actual soft-tissue outcome that are similar to a desired soft-tissue outcome and a virtual prosthesis for a current patient. The method further includes using design features from the actual prosthesis from the identified previous patient to develop a final design for the prosthesis for the current patient.
In yet another alternative, a method of designing a dental prosthesis for a current patient comprises identifying, within a database, a subset of previous patients from a plurality of patients that had the same tooth replaced as the current patient is having, and identifying, from the subset of previous patients, a first previous patient that has an actual prosthesis that is similar to a virtual prosthesis for a current patient. The method further includes using design features from the actual prosthesis from the identified first previous patient to develop a final design for the prosthesis for the current patient.
In another alternative, the present invention is a method of designing a dental prosthesis for a current patient, comprising receiving scan data from a mouth of a current patient, and, by use of the scan data, locating a dental implant that is installed in the mouth of the current patient. The method further includes, by use of the scan data, developing a desired soft-tissue outcome and a desired prosthesis shell for the current patient. The desired prosthesis shell representing an estimated volume adjacent to the dental implant that is to be occupied by the prosthesis. The method also includes (i) identifying, within a database, a first previous patient and a second previous patient each of whom has at least two clinical conditions similar to clinical conditions of the current patient, (ii) accessing, from the database, design information for a first prosthesis used on the first previous patient and for a second prosthesis used on the second previous patient, and (iii) based on the design information and the desired prosthesis shell, developing a final design for the dental prosthesis for the current patient.
Additional aspects of the present disclosure will be apparent to those of ordinary skill in the art in view of the detailed description of various implementations, which is made with reference to the drawings, a brief description of which is provided below.
The foregoing and other advantages of the disclosure will become apparent upon reading the following detailed description and upon reference to the drawings.
While the present disclosure is susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and will be described in detail herein. It should be understood, however, that the present disclosure is not intended to be limited to the particular forms disclosed. Rather, the present disclosure is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure as defined by the appended claims.
1C, and 1D illustrate steps that may be taken within a procedure for designing a patient-specific prosthesis after a dental implant 10 has been installed in the patient. In this example, the patient requires the prosthesis for tooth #9 (using the conventional tooth-numbering system), which is the location at which the implant 10 has been placed as shown in
In
In
Additionally,
As will be described in more detail below, the clinical locations 48 receive information concerning patients having a dental implant restored, such as the one described relative to
Information regarding the manufacturing of the prosthesis is transferred between the prosthetic manufacturing facility 49 and the prosthesis design system 40. For example, if the modeling derived from the scan data (e.g.,
Alternatively, a design facility 50 can be separate and distinct from both the prosthetic manufacturing facility 49 and the clinical location 48. The design facility 50 is linked to the prosthesis design system 40 (and can be considered a part of the prosthesis design system 40) and develops models (e.g.,
The database 42 can organize the data for the patients in various ways, as the skilled artisan would appreciate. Table I below illustrates the types of information that can be stored in the database 42 for the patients. The information in Table I relates primarily to clinical factors for each patient. However, the information stored in the database 42 for each patient will typically include information related to the (i) raw scan data from the mouth (e.g., images), (ii) the models derived and developed based on the scan data, (iii) the specific design details of the prosthesis (abutment and crown), (iv) the desired soft-tissue outcome before the prosthesis was installed, (v) the actual soft-tissue outcome after the prosthesis was installed (possibly over specified periods of time), and (vi) quantitative or qualitative indicators of whether the patient's actual soft-tissue outcome met the desired soft-tissue outcome (i.e., indicating how well the soft-tissue outcome was predicted). Some of the information will be discussed below.
As suggested by Table I, the patient's name is not needed. Each patient can be assigned a number or some other unique identifier that is acceptable under Health insurance Portability and Accountability Act (HIPAA). The unique identifier allows information to be stored in association with each patient. Additionally, the other basic clinical information needed for each patient includes the tooth number of the tooth (or teeth) being replaced. Each of the clinical factors will now be briefly discussed.
Age:
While it is not necessary to exactly match a current patient's age with previous patients' ages, the age factor is intended to match the relative ages, such as within 5 years or 3 years (±5 years or ±3 years). As one example illustrating the need for the age factor, a person of age 60 is not expected to have the same type of soft-tissue outcome as a person in their 20's or 30's.
Sex:
The sex factor recognizes the different anatomical sizes that generally exist between the teeth of a man and the teeth of a woman. In an alternative embodiment, the dimensions of the replaced tooth may be used to separate and distinguish sizes without the need for knowing the patient's sex.
Race:
Race can be defined in various ways, such as the manner used by the U.S. Office of Management and Budget (OMB) for census purposes, which includes the categories of White (W), Black or African American (BAA), American Indian or Alaska Native (AI), Asian (AS), and Native Hawaiian or Other Pacific Islander (PI). This category is helpful because the size of the tooth being replaced, as well as the gingival tissue, may be different based on the patient's race.
Bone Type:
There are four basic types of bone that can be found in the maxilla and mandible. Type I bone is very hard and dense. This type of bone has less blood supply than all of the rest of the types of bone. The blood supply is required for the bone to harden or calcify the bone next to the implant. Type II bone is not as hard as Type I. It is often preferred for certain types of placement of implants. Type III bone is less dense than Type II. Because the density is not as great as Type II, it takes more time to integrate with an implant. Type IV bone is the least dense of all of the bone types. Type IV bone takes the longest length of time to integrate with the implant. Bone grafting or augmentation of bone may be required often required when Type IV bone is encountered.
Implant Location:
This factor considers the location of the implant's table (i.e., the top surface), which is the surface of the implant that engages the lower end of the abutment. The location of the implant's table can be sub-crestal (below the outer bone surface), crestal (substantially at the outer bone surface), or supra-crestal (above the outer bone surface). Alternatively, the implant location can be provided in a dimensional format that indicates the location of implant's table relative to the outer bone surface in terms of a dimension or ranges of dimensions (0.0 mm<“implant location below crestal bone”<0.5 mm; 0.5 mm<“implant location below crestal bone”<1.0 mm; etc.)
Soft-Tissue Displacement:
Typical healing abutments are round in profile, but the artificial prostheses that eventually replace the healing abutments are not. Thus, the soft tissue may heal around the healing abutments creating a gingival emergence profile that approximated the size and contour of the healing abutment and not the size and contour of the final prosthesis that will eventually be attached to the implant. The differences between the emergence profile of the patient's soft tissue and the installed final prosthesis may require gingival tissue to be displaced, which may have an effect on the resultant aesthetics (e.g., the visual look of the patient's gingival tissue abutting the final prosthesis). Tissue displacement can be categorized in many ways. In one simplistic categorization, the amount of tissue to be displaced can be (i) positive (+) in that the prosthesis is smaller than the aperture of the healed soft tissue creating a volumetric gap between the healed soft tissue and the prosthesis into which the soft issue can move, (ii) negative (−) in that the prosthesis is larger than the aperture of the healed soft tissue and will force the soft tissue outwardly away from the prosthesis, or (iii) neutral (0) in that (+) in that the prosthesis is approximately the same size as the aperture of the healed soft tissue. Table I above uses this type of categorization for the clinical factor of soft-tissue displacement.
Alternatively, soft-tissue displacement can be represented by a more mathematical function or quantitatively. The volumetric shape of soft tissue adjacent the implant site may be known by knowing the size of the healing abutment, or by merging scans/images of the soft-tissue and hard tissue, as discussed in U.S. Publication No. 2011/0129792, which is hereby incorporated by reference in its entirety. Once this volumetric information for the soft tissue is known, then the amount soft tissue to be displaced can be calculated by knowing the prosthesis' dimensions. Or, the amount of soft-tissue displacement as a function of distance from the implant's table can be calculated, such that it may be a positive displacement in some areas and a negative displacement in other areas.
The systems and method contemplate the scanning of the soft-tissue after a healing abutment has been used. It may be that the healing abutment itself (dimensions and shape) is a clinical factor, and the system 40 conducts a search to locate previous patients that used similar (or the same) healing abutment. Thus, if the scanned image information for each of previous patients includes a scan of the gingival tissue (with or without the healing abutment) after being shaped by a healing abutment, that information may play a part in locating a previous patient with the actual soft-tissue outcome that is closest to what is desired for the current patient.
Loading Timeframe:
The loading timeframe indicates whether the patient underwent the more typical two-stage implant-installation approach where the implant is “buried” under the soft-tissue and allowed to osseointegrate for a period of time. Or, the patient may have been involved in an immediate loading situation, usually with a temporary prosthesis.
Other Factors:
There are other clinical factors that may influence the manner in which the patient will heal. For example, the patient's health factors (e.g. diabetic) or environmental factors (e.g. smoking) may affect the healing process.
By providing the various clinical factors, the database 42 can be easily searched to locate patients having similar clinical factors. This is advantageous when designing the prosthesis for a current patient, as discussed in the examples below. Also, it should be understood that the listed clinical factors are exemplary, and not all of the aforementioned clinical factors may needed such that the database 42 stores less information. And, it should be equally noted that other non-listed clinical factors can be included as welt.
In a first example, a white woman aged 43 is having tooth #9 restored by use of a dental implant and she is being treated at the clinical location 48a in
To develop the prosthesis for the current patient, the prosthesis design system 40 locates previous patients that have similar clinical factors. Table II below provides the results of such a search that locates four previous patients (i.e., Patients Nos. 00004, 00012, 00113, and 00229) with similar clinical conditions as the current patient.
While the four previous patients have similar clinical conditions, there can still be a wide variety of different aesthetics involved in each case.
In one embodiment that may be used in
In one preferred embodiment, the operator uses inputs to alter certain aspects of the “shell” of the prosthesis for Patient No. 00004. For example, if the gingival contouring of Patient No. 00004 was very similar to what is desired for the current patient, the subgingival aspects of the “shell” of the current patient can be adjusted to be more like the subgingival aspects of the “shell” of the Patient No. 00004. And because the supra-gingival aspect of the “shell” typically has little to do with gingival contouring because it is not in contact with the soft tissue, the supra-gingival aspect of the shell of the current patient can be dictated more by the current patient's existing teeth than Patient No. 00004. In other words, the subgingival aspects of the prosthetic design for the current patient is more driven by the previous patient(s) subgingival designs, while the supra-gingival aspects of the prosthetic design for the current patient are more driven by the neighboring actual teeth of the current patient.
In yet a further alternative, the design facility 50 has a known set of design parameters and rules which provides for the automatic modification of the prosthesis used for Patient No. 00004 to design the prosthesis for the current patient. The rules and parameters would include, for example, a minimum amount of material for the post region 76 of the abutment 72 and the minimum thickness for regions of the crown 74. Thus, if the operator were to select a fourth icon 88 (“Auto-modify”) on the computer display 52, a comparison would be conducted of the “shell” (exterior outline/profile) of the desired prosthesis 30 (
In these embodiments, once of the final design is completed, the final design is sent to a prosthetic manufacturing facility 49 (
Based on the searching at step 108, one of the previous patients is selected with an actual soft-tissue outcome and actual prosthesis that is best suited for the desired outcome for the current patient at step 110. At step 112, the prosthesis for the selected previous patient is used as the baseline design for the prosthesis for the current patient. At step 114, modifications are made to the baseline design so as to develop the final design for the prosthesis for the current patient. The final design of the prosthesis for the current patient (abutment and crown) can then be sent to the prosthetic manufacturing facility 49 (or facilities) at step 116. Once the final design has been manufactured, it can be sent to the clinical location 48 and installed on the implant 10 to the current patient at step 118.
Alternatively, instead of operator interaction and selection at steps 134 and 136, the method can use a shape-matching algorithm to identify one of the previous patients within the smaller subset at step 138. After identifying the previous patient with the actual soft-tissue outcome and actual prosthesis that is the closest to the desired soft-tissue outcome for the current patient, an operator can then begin to modify the baseline design of the prosthesis for the identified previous patient to better fit the current patient.
The methods discussed with respect to the present invention have employed a dual comparison in which the shapes and dimensions of the actual and desired soft-tissue outcomes represent a first comparison, and the overall shape and profile of the actual and desired (i.e., from the model) prostheses represent a second comparison. In such and embodiment, once previous patients in the database 42 have been identified as having actual soft-tissue outcomes that are relatively close to the current patient, then a secondary comparison can be performed on those identified previous patients to determine which one used a prosthesis that is closest in its overall profile to the desired prosthesis the “shell” prosthesis disclosed in the model of
Alternatively, because the shape and dimensions of the actual soft-tissue outcome of the previous patient are relatively close to (i.e., there is some relationship between them) the desired shape and dimensions of the soft tissue of the current patient, there is a presumption that the prostheses between the two patients should be relatively close as well. In this situation, only the actual and desired soft-tissue outcomes are compared to identify a previous patient who has an actual soft-tissue outcome that is the closest to the desired soft-tissue outcome. That previous patient's prosthesis (abutment and crown) is then used as the starting point for the current patient's prosthesis.
After the prosthesis has been installed on the implant, an image can be stored of the patient's final soft-tissue outcome at step 158. It should be noted, however, that multiple images after the installation of the prosthesis on the implant can be taken over a period of time because the dimensions and shape of the soft tissue along the prosthesis may change. At some point in time (preferably when the patient's soft tissue has reached a steady-state condition), a comparison is taken between the patient's desired soft-tissue outcome in the patient's actual soft-tissue outcome at step 160. This comparison determines how accurate a patient's soft-tissue outcome can be predicted. Preferably, the comparison focuses on certain soft-tissue parameters so as to identify differences between the desired soft-tissue outcome and the patient's actual soft-tissue outcome, as indicated in step 162. The soft tissue parameters may include for example the soft, tissue contour, the soft tissue height, and the soft tissue inter-papillae fullness, which are described below with reference to
Assuming
Again, assuming
Assuming
The benefit of recording the comparisons between the desired soft-tissue outcome and the actual soft-tissue outcome is that trends can be seen in the clinical data acquired from the previous patients and used to augment or enhance the design of the prosthesis for current patients. Because the soft tissue growth and attachment along the sides of prosthesis can relate to many factors, these trends can help to develop designs for specific teeth that are being replaced or for specific types of patients. In other words, what works well on tooth number 9 may not work well for tooth number 12. Or, what may work well for a 65-year-old male may not work well for a 23-year-old female.
This Example 2 is similar to Prosthesis Design Example 1. However, additional prosthetic-based clinical factors and predicted soft-tissue outcomes are analyzed from previous patients to arrive at the final design for the current patient. And, the design process is more automated and requires less (or no) manual operator inputs or evaluations.
In Prosthesis Design Example 2, while Patient No. 00004 had the closest actual outcome relative to the desired outcome for the current patient, the data from patient number 00004 related to the prediction in the actual soft-tissue outcome was not entirely accurate. Specifically, for Patient No. 00004, the actual soft tissue height “H” did not match the desired soft tissue height, such as the outcome shown in
Accordingly, the database 42 can be used to locate prosthetic-based clinical factors for previous patients that led to more predictable soft-tissue outcomes. Table III is similar to Table II above in that previous patients have been identified as having potentially beneficial information for the design of the current patient based on their clinical factors (e.g., tooth number, age, sex, race). However, Table III includes ten previous patients along with their prosthetic-based clinical factors and information related to how well the soft-tissue outcome for each of the previous patients was predicted.
In Table III, the desired soft-tissue outcome and prosthesis for the current patient most closely matches the actual soft-tissue outcome and prosthesis of previous Patient No. 00004. However, for Patient No. 00004, her actual soft-tissue outcome did not exactly match her desired soft-tissue outcome. As noted in the 7th column, the Predicted Soft-Tissue Height was not met.
On the other hand, two other previous patients—Patients No. 00389 and 01492—may have had prosthetic geometries that did not match as well to the current patient as Patient No. 00004. But, the Predicted Soft-Tissue Contour, Predicted Soft-Tissue Height, and Predicted Inter Papilla Fullness were met, as noted by the fact that those two previous patients' desired soft-tissue outcome and their actual soft-tissue outcomes were substantially the same. However, for previous Patients Nos. 00389 and 01492, the abutment characteristics (e.g., sub-gingival features of the prosthesis) were different because neither was “Platform Switched” and both had a type of “Abutment Micro-Structure” that is designed to help hold the soft tissue along the side of the prosthesis.
Accordingly, based on the data from the previous patient Nos. 00004, 00389 and 01492, the prosthesis design system 40 may automatically develop a design for the current patient's prosthesis. The design has a geometry similar to patient No. 00004, except that it is not Platform Switched (i.e., its base has the same diameter as the table of the implant). And, its outer surface that is intended to engage the soft-tissue has the same type of Abutment Micro-Structure as Previous Patient Nos. 00389 and 01492.
Based on the searching at step 308, previous patients are selected at step 310 with an actual soft-tissue outcome and prosthesis that are the closest to (i.e., related to) the desired outcome and prosthesis for the current patient. It should be noted that the comparison of the actual prostheses of previous patients to the “shell” of the prosthesis of the current patient (FIG. ID) may focus primarily (or entirely) on matching sub-gingival aspects (not supra-gingival aspects) because sub-gingival aspects have more of a direct impact or influence on the soft-tissue outcome. Within step 310, one previous patient may be selected that is the closest to the geometry of the actual soft-tissue outcome and prosthesis for the current patient, and a second previous patient may be selected because the prosthesis used by that second previous patient had a more predicted soft-tissue outcome (like Previous Patient Nos. 00389 and 01492 above). At step 312, the features for the prosthesis for the selected previous patients are merged to develop a database driven design for the prosthesis for the current patient. The final design of the prosthesis for the current patient (abutment and crown) can then be sent to the manufacturing facility 49 (or facilities) at step 314. Once the final design has been manufactured, it can be sent to the clinical facility 48 and installed on the implant 10 for the current patient at step 316. And, to build and supplement the database 42, the current patient's soft-tissue outcome is ultimately checked against the desired outcome after installation on the implant 10, such that the current patient becomes a “previous patient” at a later point in time and the prosthesis for the current patient may be used as a baseline design for a similarly situated future patient.
This example is similar to Prosthesis Design Example 2 in that additional prosthetic-based clinical factors are analyzed from previous patients to arrive at the final design for the current patient. However, in this example, the geometry of the abutment other previous patients is used to alter a baseline design.
Table IV is similar to Table III but illustrates how the previous patients' information can be used to alter a geometric design feature, which in this example is the Implant-to-Margin distance (measured from the implant's table to the facial midpoint of the abutment as shown in
On the other hand, two other previous patients—Patient Nos. 00389 and 01492—may have prosthetic geometries that did not match as well to the current patient's geometry as Patient No. 00301. But, the Predicted Soft-Tissue Contour, Predicted Soft-Tissue Height, and Predicted Inter Papilla Fullness were met in that those two previous patients' desired soft-tissue outcome and their actual soft-tissue outcomes were substantially the same. Thus, an analysis can be conducted by the prosthesis design system 40 to identify a trend or difference variable) that may have impacted the different soft-tissue outcomes.
Specifically, for previous Patients Nos. 00389 and 01492, the abutment characteristics were different from Patient No. 00310 in that both had a significantly larger Implant-to-Margin distance (2.2 mm and 2.6 mm) than the Implant-to-Margin distance for Patient No. 00301 (1.6 mm). Because all three abutments have an Abutment Micro-Structure, the prosthesis design system 40 isolates this different variable as being a possible contributing factor to the predictive soft-tissue successes of Patients Nos. 00389 and 01492. For example, perhaps the additional surface area created by the longer length of the Implant-to-Margin distance permitted better connective tissue attachment along the surface of the ZrO2 abutment having the Abutment Micro-Structure.
Accordingly, based on the information from the Previous Patient Nos. 00301, 00389 and 01492, the prosthesis design system 40 automatically develops a design for the current patient's prosthesis. The design has an overall geometry similar to patient No. 00301, except that it increases the Implant-to-Margin distance from 1.6 mm to 2.4 mm (i.e., average between 2.2 mm and 2.6 mm).
Accordingly, to design the prosthesis 402 for the current patient, the primary geometry is taken from the prosthesis 404, but a larger dimension exists between the implant and the margin 430 in the abutment 410 (similar to Patient No. 00389 and Patient No. 01492). Other geometrical design features in the abutment 410 and the crown 414 will be substantially more like those same features found in the prosthesis 404 for Patient No. 00301. As just one example, the maximum abutment margin width “X” for the abutment 410 is very similar to the same abutment dimension in the prosthesis 404 used in Patient No. 00301, but is different from those corresponding abutment dimensions “Y” and “Z” for the prosthesis 406 and the prosthesis 408, respectively.
This example is similar to Prosthesis Design Example 2 and Example 3 in that additional prosthetic-based clinical factors are analyzed from previous patients to arrive at the final design for the current patient. However, Prosthesis Design Example 4 include developing a final prosthesis for the current patient based on interpolating between two geometries for two prosthesis used onto previous patients, both of whom had accurately predicted soft-tissue outcome. As explained below, Table V below includes prosthetic-based clinical factors that are more focused on a few of the basic geometrical dimensions for the abutment and the crown.
Table V is similar to Tables III and IV, but illustrates how the previous patients' information can be used to alter a geometric design feature by interpolation, which in this example is the Implant-to-Margin dimension shown in
As indicated in Table V, Patient No. 01492 has a similar sized prosthetic length and abutment length as Patient No. 00389. And, the final outcome for Patient No. 01492 was also predicted, like Patient No. 00389. However, the desired outcome for the soft tissue location (i.e., the Soft-Tissue Height) for the current patient is not as far down the prosthesis length coronally as the final outcome for Patient No. 01492. This difference in the soft-tissue location may be determined by comparing actual images of Patient Nos. 00389 and 01492 with the desired outcome (e.g.,
Accordingly, the prosthetic design system 40 adjusts the Implant-to-Margin dimension so as to be between 2.2 mm and 2.6 mm, such as 2.4 mm. In other words, the system interpolates the information for the Implant-to-Margin dimension for Patient Nos. 00389 and 01492 to arrive at the design for the current patient. While the final design for the prosthesis (abutment and crown) for the current patient will be most similar to the previous Patient No. 00389, the Implant-to-Margin dimension for the design will be altered to 2.4 mm (instead of 2.2 mm).
Accordingly, to design the prosthesis 602 for the current patient, the primary geometry is taken from the prosthesis 604. But, a different dimension is chosen for the Implant-to-Margin dimension that is between the corresponding dimensions for the prosthesis 604 (2.2 mm) and the prosthesis 606 (2.6 mm).
Consequently, the Prosthesis Design Examples 2, 3, and 4 illustrate how dimensional changes and material changes can be made to the prosthesis based on information that is stored in the database 42 for multiple previous patients. In each of these examples, the prosthetic design system 40 is used to locate previous patients with (i) similar clinical factors as the current patient and (ii) similar prosthetic-based clinical factors. Additionally information about the previous patients' soft-tissue outcomes (both the actual soft-tissue outcomes, and differences in the accuracies of the previous patients' soft-tissue outcomes) may also be used to develop a final design for the prosthesis for the current patient.
Furthermore, in the Prosthesis Design Examples 2, 3, and 4, the methodology has been described as being more automated in that the prosthesis design system 40 performs all of the tasks/steps (or nearly all of the task/steps) needed to arrive at the final design for the current patient. However, it should be understood that the methodology can include additional manual steps by an operator at the clinical location 48, the design facility 50, and/or the prosthetic manufacturing facility 49. As an example, the prosthetic design system 40 could identify to an operator that the actual soft tissue outcome for Patient No. 00004 was not as predicted. The prosthetic design system 40 could then be prompted by the operator to identify other similarly situated previous patients that had predicted soft-tissue outcomes and any potential geometric or material differences in those previous patients that may have led to the predicted soft-tissue outcome. After identifying these previous patients and displaying them on a computer display to the operator, the operator may be able to select whether to implement the geometric difference or the material difference in developing the final design of the prosthesis for the current patient.
In the previous Prosthesis Design Examples 1, 2, 3, and 4, the initial scan of the current patient's mouth occurs after the placement of the implant, capturing the image of the soft tissue after the implant surgery. While not discussed previously, the prosthetic design system 40 could be implemented to dictate the exact healing abutment (width, height, and emergence profile) to be chosen for the patient after stage-one osseointegration has occurred. In other words, in the Prosthesis Design Examples 1, 2, 3, and 4, each previous patient may have information about the details of the healing abutment stored in the database 42 (like the information on the abutment and prosthesis) and the current patient would receive a recommendation for the healing abutment to be used prior to the prosthesis, which is another aspect of the patient's design that would be (performed by the prosthetic design system 40. The healing abutment would begin developing the soft-tissue contours and shapes into which the custom prosthesis will eventually be placed when it is attached to the implant And, because some procedures may call for the use of a temporary prosthesis in stage-two surgery (instead of a healing abutment), data for a temporary prosthesis can also be stored in the database 42 in lieu of or in addition to the healing-abutment data.
As yet a further alternative, the initial scan of the current patient's mouth could occur after a stage-two healing of the soft tissue such that the soft tissue is in a more final and healed condition. That could be one of the scans (or the only scan) used for developing the model that dictates the desired soft-tissue outcome for the current patient.
While the present invention has been described relative to the development of a design for a prosthesis to be mounted on a dental implant that has already been installed in the patient's mouth, the present invention contemplates a design system 40 in which the overall surgical process, including the selection and installation of the dental implant, can be based upon information from previous patients. In this embodiment, initial scan(s) of the patient would include the details of the underlying bone structure (likely through a CT scan) and the soft tissue, and the current patient's model (
The present invention contemplates that, over a significant period of time, the predictability of a current patient's soft tissue outcome should become more accurate because the database 42 will be using information for a current patient's design that is based on previous patients who have achieved predictable and successful soft-tissue results. Accordingly, as time progresses, there should be an increase in the percentage of previous patients stored in the database 42 who have positive and predictable soft-tissue outcomes. In summary, the positive soft-tissue results achieved by patients should continue to increase over a period of time.
While the present disclosure primarily discusses the entire “shell” being matched, the “shell” can be divided into the sub-gingival aspect and supra-gingival aspect (or a lower portion and upper portion), as described above. The sub-gingival aspect has the most direct impact on the resultant gingival contours and, therefore, is most relevant in terms of predictive modeling. While it might be desirous to match the entire shell so as to minimize the amount of design work/input required by the operator, it should be noted that the matching can be primarily (or totally) focused on matching the sub-gingival aspects. There is oftentimes little (if any) “prediction” necessary with the supra-gingival aspect of the prosthetic design because nothing is being displaced and/or contoured with the supra-gingival geometry (i.e., what you see if what you get). To make the predictive model more efficient and robust, the present invention contemplates a prosthetic design system 40 primarily (or totally) matching the sub-gingival geometries of the prosthesis (and soft-tissue outcomes) between the current patient and previous patients. Once this is matched, the supra-gingival geometry can be developed in the computer (or with some operator assistance) to match the supra-gingival aspect of the current patient's “shell” design and will appear the same once installed.
Further, it should be noted that the present invention can be used to alter the design for a current patient's prosthesis that has already been substantially designed (as opposed to be being simply a “shell”). For example, a more finalized design for a current patient's prosthesis may include details for an abutment and/or a crown. The more finalized design (and possibly the desired soft-tissue outcome) can then be compared against the information for previous patients in the database 42 to identify previous patient(s) that had predictable actual soft-tissue outcomes. Based on those identified previous patient(s), the more finalized design can be altered to include design features corresponding to the identified previous patient(s) that may help to achieve a predicable soft-tissue outcome for the current patient.
While the present disclosure has been described with reference to one or more particular embodiments and implementations, those skilled in the art will recognize that many changes may be made thereto without departing from the spirit and scope of the present disclosure. Each of these embodiments and implementations and obvious variations thereof is contemplated as falling within the spirit and scope of the present invention, which is set forth in the claims that follow.
This application is a divisional application of U.S. patent application Ser. No. 13/770,921, filed Feb. 19, 2013, the contents of which are incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3732621 | Bostrom | May 1973 | A |
3919772 | Lenczycki | Nov 1975 | A |
3958471 | Muller | May 1976 | A |
4011602 | Rybicki et al. | Mar 1977 | A |
4086701 | Kawahara et al. | May 1978 | A |
4177562 | Miller et al. | Dec 1979 | A |
4294544 | Altschuler et al. | Oct 1981 | A |
4306862 | Knox | Dec 1981 | A |
4341312 | Scholer | Jul 1982 | A |
4547157 | Driskell | Oct 1985 | A |
4611288 | Duret et al. | Sep 1986 | A |
4615678 | Moermann et al. | Oct 1986 | A |
4624673 | Meyer | Nov 1986 | A |
4663720 | Duret et al. | May 1987 | A |
4713004 | Linkow et al. | Dec 1987 | A |
4758161 | Niznick | Jul 1988 | A |
4767331 | Hoe | Aug 1988 | A |
4772204 | Soderberg | Sep 1988 | A |
4793808 | Kirsch | Dec 1988 | A |
4821200 | Oberg | Apr 1989 | A |
4842518 | Linkow et al. | Jun 1989 | A |
4850870 | Lazzara et al. | Jul 1989 | A |
4850873 | Lazzara et al. | Jul 1989 | A |
4854872 | Detsch | Aug 1989 | A |
4856994 | Lazzara et al. | Aug 1989 | A |
4872839 | Brajnovic | Oct 1989 | A |
4906191 | Soderberg | Mar 1990 | A |
4935635 | O'harra | Jun 1990 | A |
4955811 | Lazzara et al. | Sep 1990 | A |
4964770 | Steinbichler et al. | Oct 1990 | A |
4988297 | Lazzara et al. | Jan 1991 | A |
4988298 | Lazzara et al. | Jan 1991 | A |
5000685 | Brajnovic | Mar 1991 | A |
5006069 | Lazzara et al. | Apr 1991 | A |
5015183 | Fenick | May 1991 | A |
5015186 | Detsch | May 1991 | A |
5030096 | Hurson et al. | Jul 1991 | A |
5035619 | Daftary | Jul 1991 | A |
5040983 | Binon | Aug 1991 | A |
5064375 | Jorneus | Nov 1991 | A |
5071351 | Green, Jr. et al. | Dec 1991 | A |
5073111 | Daftary | Dec 1991 | A |
5100323 | Friedman et al. | Mar 1992 | A |
5104318 | Piche et al. | Apr 1992 | A |
5106300 | Voitik | Apr 1992 | A |
5122059 | Durr et al. | Jun 1992 | A |
5125839 | Ingber et al. | Jun 1992 | A |
5125841 | Carlsson et al. | Jun 1992 | A |
5133660 | Fenick | Jul 1992 | A |
5135395 | Marlin | Aug 1992 | A |
5145371 | Jorneus | Sep 1992 | A |
5145372 | Daftary et al. | Sep 1992 | A |
5188800 | Green et al. | Feb 1993 | A |
5195892 | Gersberg | Mar 1993 | A |
5205745 | Kamiya et al. | Apr 1993 | A |
5209659 | Friedman et al. | May 1993 | A |
5209666 | Balfour et al. | May 1993 | A |
5213502 | Daftary | May 1993 | A |
5237998 | Duret et al. | Aug 1993 | A |
5246370 | Coatoam | Sep 1993 | A |
5257184 | Mushabac | Oct 1993 | A |
5281140 | Niznick | Jan 1994 | A |
5286195 | Clostermann | Feb 1994 | A |
5292252 | Nickerson et al. | Mar 1994 | A |
5297963 | Dafatry | Mar 1994 | A |
5312254 | Rosenlicht | May 1994 | A |
5316476 | Krauser | May 1994 | A |
5320529 | Pompa | Jun 1994 | A |
5322436 | Horng et al. | Jun 1994 | A |
5334024 | Niznick | Aug 1994 | A |
5336090 | Wilson, Jr. et al. | Aug 1994 | A |
5338196 | Beaty et al. | Aug 1994 | A |
5338198 | Wu et al. | Aug 1994 | A |
5343391 | Mushabac | Aug 1994 | A |
5344457 | Pilliar et al. | Sep 1994 | A |
5359511 | Schroeder et al. | Oct 1994 | A |
5362234 | Salazar et al. | Nov 1994 | A |
5362235 | Daftary | Nov 1994 | A |
5368483 | Sutter et al. | Nov 1994 | A |
5372502 | Massen et al. | Dec 1994 | A |
5386292 | Massen et al. | Jan 1995 | A |
5401170 | Nonomura | Mar 1995 | A |
5413481 | Goppel et al. | May 1995 | A |
5417570 | Zuest et al. | May 1995 | A |
5419702 | Beaty et al. | May 1995 | A |
5431567 | Daftary | Jul 1995 | A |
5437551 | Chalifoux | Aug 1995 | A |
5440393 | Wenz | Aug 1995 | A |
5452219 | Dehoff et al. | Sep 1995 | A |
5458488 | Chalifoux | Oct 1995 | A |
5476382 | Daftary | Dec 1995 | A |
5476383 | Beaty et al. | Dec 1995 | A |
5492471 | Singer | Feb 1996 | A |
5497336 | Andersson et al. | Mar 1996 | A |
5527182 | Willoughby | Jun 1996 | A |
5533898 | Mena | Jul 1996 | A |
5538426 | Harding et al. | Jul 1996 | A |
5547377 | Daftary | Aug 1996 | A |
5556278 | Meitner | Sep 1996 | A |
5564921 | Marlin | Oct 1996 | A |
5564924 | Kwan | Oct 1996 | A |
5569578 | Mushabac | Oct 1996 | A |
5580244 | White | Dec 1996 | A |
5616899 | Recigno | Apr 1997 | A |
5651675 | Singer | Jul 1997 | A |
5658147 | Phimmasone | Aug 1997 | A |
5662476 | Ingber et al. | Sep 1997 | A |
5674069 | Osorio | Oct 1997 | A |
5674071 | Beaty et al. | Oct 1997 | A |
5674073 | Ingber et al. | Oct 1997 | A |
5681167 | Lazarof | Oct 1997 | A |
5685715 | Beaty et al. | Nov 1997 | A |
5718579 | Kennedy | Feb 1998 | A |
5725376 | Poirier | Mar 1998 | A |
5733123 | Blacklock et al. | Mar 1998 | A |
5759036 | Hinds | Jun 1998 | A |
5768134 | Swaelens et al. | Jun 1998 | A |
5800168 | Cascione et al. | Sep 1998 | A |
5810592 | Daftary | Sep 1998 | A |
5813858 | Singer | Sep 1998 | A |
5846079 | Knode | Dec 1998 | A |
5851115 | Carlsson et al. | Dec 1998 | A |
5857853 | Van Nifterick et al. | Jan 1999 | A |
5871358 | Ingber et al. | Feb 1999 | A |
5873722 | Lazzara et al. | Feb 1999 | A |
5938443 | Lazzara et al. | Aug 1999 | A |
5964591 | Beaty et al. | Oct 1999 | A |
6008905 | Breton et al. | Dec 1999 | A |
6093023 | Sala Meseguer | Jul 2000 | A |
6120293 | Lazzara et al. | Sep 2000 | A |
6129548 | Lazzara et al. | Oct 2000 | A |
6135773 | Lazzara | Oct 2000 | A |
6257890 | Khoury et al. | Jul 2001 | B1 |
6273720 | Spalten | Aug 2001 | B1 |
6296483 | Champleboux | Oct 2001 | B1 |
6312260 | Kumar | Nov 2001 | B1 |
6334853 | Kopelman | Jan 2002 | B1 |
6402707 | Ernst | Jun 2002 | B1 |
6406295 | Mahler | Jun 2002 | B1 |
6558162 | Porter | May 2003 | B1 |
6790040 | Amber et al. | Sep 2004 | B2 |
6793491 | Klein et al. | Sep 2004 | B2 |
7035702 | Jelonek et al. | Apr 2006 | B2 |
7059856 | Marotta | Jun 2006 | B2 |
7425131 | Amber et al. | Sep 2008 | B2 |
7551760 | Scharlack et al. | Jun 2009 | B2 |
7758345 | Christensen | Jul 2010 | B1 |
7987099 | Kuo | Jul 2011 | B2 |
7988449 | Amber et al. | Aug 2011 | B2 |
8185224 | Powell et al. | May 2012 | B2 |
8244390 | Kuo | Aug 2012 | B2 |
8257083 | Berckmans, III et al. | Sep 2012 | B2 |
8353703 | Amber et al. | Jan 2013 | B2 |
8628327 | Blaisdell et al. | Jan 2014 | B1 |
9326834 | Morales | May 2016 | B2 |
9839496 | Herrington et al. | Dec 2017 | B2 |
20010034010 | MacDougald et al. | Oct 2001 | A1 |
20020160337 | Klein et al. | Oct 2002 | A1 |
20040236389 | Fink | Nov 2004 | A1 |
20080124676 | Marotta | May 2008 | A1 |
20080154419 | Cheng et al. | Jun 2008 | A1 |
20080241789 | Mundorf | Oct 2008 | A1 |
20090087817 | Jansen et al. | Apr 2009 | A1 |
20090220134 | Cahill | Sep 2009 | A1 |
20090264894 | Wasielewski | Oct 2009 | A1 |
20100105011 | Karkar et al. | Apr 2010 | A1 |
20100240012 | Lange et al. | Sep 2010 | A1 |
20100296710 | Schneider et al. | Nov 2010 | A1 |
20110129792 | Berckmans, III et al. | Jun 2011 | A1 |
20110276159 | Chun et al. | Nov 2011 | A1 |
20110306008 | Suttin | Dec 2011 | A1 |
20120095732 | Fisker | Apr 2012 | A1 |
20120106812 | Stone-Collonge et al. | May 2012 | A1 |
20120322025 | Ozawa et al. | Dec 2012 | A1 |
20130226534 | Fisker et al. | Aug 2013 | A1 |
20130332128 | Miles | Dec 2013 | A1 |
20140234801 | Herrington et al. | Aug 2014 | A1 |
20150132718 | Kerschensteiner | May 2015 | A1 |
Number | Date | Country |
---|---|---|
2114323 | Oct 1971 | DE |
3531389 | Mar 1987 | DE |
4028855 | Mar 1992 | DE |
0442855 | Aug 1991 | EP |
0583829 | Feb 1994 | EP |
0657146 | Jun 1995 | EP |
0727193 | Aug 1996 | EP |
0747017 | Dec 1996 | EP |
2159724 | Mar 2010 | EP |
2759896 | Aug 1998 | FR |
1291470 | Oct 1972 | GB |
05212063 | Aug 1993 | JP |
06154252 | Jun 1994 | JP |
09218916 | Aug 1997 | JP |
WO-8502337 | Jun 1985 | WO |
WO-9426200 | Nov 1994 | WO |
WO-0134057 | May 2001 | WO |
Entry |
---|
“U.S. Appl. No. 13/770,921, Advisory Action dated Apr. 6, 2016”, 5 pgs. |
“U.S. Appl. No. 13/770,921, Advisory Action dated Nov. 6, 2015”, 3 pgs. |
“U.S. Appl. No. 13/770,921, Final Office Action dated Oct. 19, 2015”, 12 pgs. |
“U.S. Appl. No. 13/770,921, Final Office Action dated Dec. 14, 2016”, 13 pgs. |
“U.S. Appl. No. 13/770,921, Non Final Office Action dated Feb. 26, 2015”, 17 pgs. |
“U.S. Appl. No. 13/770,921, Non Final Office Action dated Jun. 14, 2016”, 14 pgs. |
“U.S. Appl. No. 13/770,921, Non Final Office Action dated Jul. 3, 2017”, 15 pgs. |
“U.S. Appl. No. 13/770,921, Notice of Allowance dated Aug. 8, 2017”, 7 pgs. |
“U.S. Appl. No. 13/770,921, Response filed Mar. 21, 2016 to Final Office Action dated Oct. 19, 2015”, 14 pgs. |
“U.S. Appl. No. 13/770,921, Response filed Apr. 13, 2017 to Final Office Action dated Dec. 14, 2016”, 16 pgs. |
“U.S. Appl. No. 13/770,921, Response filed Apr. 18, 2016 to Advisory Action dated Apr. 6, 2016”, 14 pgs. |
“U.S. Appl. No. 13/770,921, Response filed Jun. 26, 2015 to Non Final Office Action dated Feb. 26, 2015”, 16 pgs. |
“U.S. Appl. No. 13/770,921, Response filed Jul. 18, 2014 to Restriction Requirement dated Jun. 9, 2014”, 9 pgs. |
“U.S. Appl. No. 13/770,921, Response filed Jul. 24, 2017 to Non Final Office Action dated Jul. 3, 2017”, 8 pgs. |
“U.S. Appl. No. 13/770,921, Response filed Oct. 14, 2016 to Non Final Office Action dated Jun. 14, 2016”, 14 pgs. |
“U.S. Appl. No. 13/770,921, Response filed Oct. 28, 2015 to Final Office Action dated Oct. 19, 2015”, 11 pgs. |
“U.S. Appl. No. 13/770,921, Restriction Requirement dated Jun. 9, 2014”, 6 pgs. |
“European Application Serial No. 14753550.4, Extended European Search Report dated Feb. 3, 2017”, 7 pgs. |
“European Application Serial No. 14753550.4, Response filed May 9, 2016 to Communication pursuant to Rules 161(1) and 162 EPC dated Oct. 28, 2015”, 2 pgs. |
“European Application Serial No. 14753550.4, Response filed Sep. 1, 2017 to Extended European Search Report dated Feb. 3, 2017”, 10 pgs. |
“International Application Serial No. PCT/US2014/014849, International Preliminary Report on Patentability dated Apr. 29, 2015”, 8 pgs. |
“International Application Serial No. PCT/US2014/014849, International Search Report dated Apr. 23, 2014”, 2 pgs. |
“International Application Serial No. PCT/US2014/014849, Written Opinion dated Apr. 23, 2014”, 10 pgs. |
“European Application Serial No. 19163882.4, Extended European Search Report dated Feb. 10, 2020”, 11 pgs. |
“European Application Serial No. 19163882.4, Partial European Search Report dated Nov. 7, 2019”, 13 pgs. |
“European Application Serial No. 19163882.4, Response filed Sep. 11, 2020 to Extended European Search Report dated Feb. 10, 2020”, 16 pgs. |
Number | Date | Country | |
---|---|---|---|
20180092719 A1 | Apr 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13770921 | Feb 2013 | US |
Child | 15808947 | US |